Clinical Trial Update: Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Usability of Abaloparatide-solid Microstructured Transdermal System (sMTS) in Postmenopausal Women With Low Bone Mineral Density (BMD) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating pharmacokinetics, pharmacodynamics, and usability of abaloparatide sMTS in postmenopausal women with low bone mineral density; complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Abaloparatide (abaloparatide)

Snippet

Sponsor: Radius Health, Inc. | Conditions: Postmenopausal Osteoporosis | Phase 1 | Status: COMPLETED | Results posted: 2023-11-22